Characterization of genomic alterations as biomarkers of immune checkpoint inhibitor (ICI) response in metastatic urothelial carcinoma (mUC).

被引：0
|
作者：
Labriola, Matthew
Zhu, Jason
Gupta, Rajan
McCall, Shannon
Jackson, Jennifer
White, James R.
Weingartner, Elizabeth
Kong, Eric
Simone, Peter
Papp, Eniko
Gerding, Kelly
Simmons, John
George, Daniel J.
Zhang, Tian
机构：
[1] Duke Med Ctr, Durham, NC USA
[2] Duke Univ, Durham, NC USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Personal Genome Diagnost Inc, Baltimore, MD USA
[5] Duke Canc Inst, Durham, NC USA
[6] Duke Univ, Duke Canc Inst, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.400
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
400
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Characterizing immune-genomic signatures associated with response to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC)
    Pramod, Nikhil
    Dawsey, Scott
    Pavicic, Paul G.
    Lodha, Roshan
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Mian, Omar Y.
    Nizam, Amanda
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Immunological correlates of response to immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC) patients (pts)
    Tzeng, Alice
    Diaz-Montero, C. Marcela
    Rayman, Patricia A.
    Kim, Jin Sub
    Pavicic, Paul G.
    Finke, James
    Barata, Pedro C.
    Lamenza, Marcelo
    Devonshire, Sarah
    Schach, Kim
    Emamekhoo, Hamid
    Ernstoff, Marc S.
    Hoimes, Christopher J.
    Rini, Brian I.
    Garcia, Jorge A.
    Gilligan, Timothy D.
    Ornstein, Moshe Chaim
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [3] Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts).
    Nizam, Amanda
    Tzeng, Alice
    Wei, Wei
    Rayman, Patricia A.
    Pavicic, Paul G.
    Makarov, Vladimir
    Juric, Ivan
    Alban, Tyler
    Swaidani, Shadi
    Sheng, Iris Yeong-Fung
    Gilligan, Timothy D.
    Gupta, Shilpa
    Diaz-Montero, C. Marcela
    Ornstein, Moshe Chaim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [4] Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Pramod, Nikhil
    Makarov, Vladimir
    Dawsey, Scott
    Pavicic, Paul G.
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Nizam, Amanda
    Mian, Omar Y.
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 670 - 670
  • [5] Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Chen, Siteng
    Zhang, Ning
    Wang, Tao
    Zhang, Encheng
    Wang, Xiang
    Zheng, Junhua
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [6] GENOMIC BIOMARKERS FOR IMMUNE-CHECKPOINT BLOCKADE RESPONSE IN METASTATIC UPPER TRACT UROTHELIAL CARCINOMA
    Silagy, Andrew W.
    DiNatale, Renzo G.
    Chowell, Diego
    Makarov, Vlad
    Pietzak, Eugene
    Solit, David
    Berger, Michael
    Hakimi, A. Ari
    Reznik, Eduard
    Bajorin, Dean
    Chan, Timothy A.
    Coleman, Jonathan A.
    JOURNAL OF UROLOGY, 2020, 203 : E379 - E379
  • [7] Treatment and outcome after Immune checkpoint inhibitors (ICI) in metastatic Urothelial Carcinoma (mUC): A European perspective
    Lista, A. Gomez de Liano
    Necchi, A.
    Lavaud, P.
    Carles Galceran, J.
    Castellano, D.
    Ravaud, A.
    Duran, I.
    van Dijk, N.
    Giannatempo, P.
    Loriot, Y.
    Morales Barrera, R.
    De Velasco Oria De Rueda, G.
    Lefort, F.
    Martinez Bernal, G.
    Raggi, D.
    Gross-Goupil, M.
    Powles, T.
    van der Heijden, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Response to platinum-based therapy (PBT) and immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC) patients (pts) with genomic alterations (GA) in homologous recombination repair (HRR) genes
    Mendiratta, Prateek
    Loehr, Andrea
    Simmons, Andrew
    Barata, Pedro C.
    Klek, Stefan
    Pritchard, Amy
    Emamekhoo, Hamid
    Funchain, Pauline
    Sohal, Davendra
    Ali, Siraj Mahamed
    Gilligan, Timothy D.
    Ornstein, Moshe Chaim
    Garcia, Jorge A.
    Rini, Brian I.
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [9] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean T.
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [10] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345